INBX
Inhibrx Inc

610
Mkt Cap
$943.45M
Volume
503,393.00
52W High
$94.57
52W Low
$10.81
PE Ratio
-6.34
INBX Fundamentals
Price
$60.92
Prev Close
$64.87
Open
$63.89
50D MA
$75.81
Beta
0.92
Avg. Volume
166,882.83
EPS (Annual)
-$9.04
P/B
25.54
Rev/Employee
$11,818.18
$1,206.27
Loading...
Loading...
News
all
press releases
Inhibrx Biosciences (NASDAQ:INBX) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS
Inhibrx Biosciences (NASDAQ:INBX - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($2.11) earnings per share for the quarter, missing analysts' consensus estimates of ($2.08) by ($0.03...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results PR Newswire SAN DIEGO, March 19, 2026 SAN DIEGO, March 19...
PR Newswire·1d ago
News Placeholder
Boothbay Fund Management LLC Boosts Holdings in Inhibrx Biosciences, Inc. $INBX
Boothbay Fund Management LLC increased its position in Inhibrx Biosciences, Inc. (NASDAQ:INBX - Free Report) by 179.2% during the third quarter, according to the company in its most recent filing...
MarketBeat·4d ago
News Placeholder
Slotnik Capital LLC Sells 142,770 Shares of Inhibrx Biosciences, Inc. $INBX
Slotnik Capital LLC cut its holdings in Inhibrx Biosciences, Inc. (NASDAQ:INBX - Free Report) by 77.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The...
MarketBeat·6d ago
News Placeholder
Inhibrx Biosciences (INBX) to Release Quarterly Earnings on Monday
Inhibrx Biosciences (NASDAQ:INBX) will be releasing its Q4 2025 earnings before the market opens on Monday, March 16. (View Earnings Report at...
MarketBeat·12d ago
News Placeholder
Inhibrx Announces Participation in Upcoming Scientific Conference
Inhibrx Announces Participation in Upcoming Scientific Conference Inhibrx Announces Participation in Upcoming Scientific Conference PR Newswire SAN DIEGO, March 2, 2026 SAN DIEGO, March 2, 2026...
PR Newswire·18d ago
News Placeholder
Readystate Asset Management LP Acquires 143,324 Shares of Inhibrx Biosciences, Inc. $INBX
Readystate Asset Management LP lifted its stake in Inhibrx Biosciences, Inc. (NASDAQ:INBX - Free Report) by 534.1% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·1mo ago
News Placeholder
Inhibrx Biosciences, Inc. $INBX Shares Sold by Credit Industriel ET Commercial
Credit Industriel ET Commercial reduced its position in Inhibrx Biosciences, Inc. (NASDAQ:INBX - Free Report) by 54.9% in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·1mo ago
News Placeholder
Inhibrx Biosciences (NASDAQ:INBX) Shares Down 6.8% - Here's What Happened
Inhibrx Biosciences (NASDAQ:INBX) Shares Down 6.8% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Short Interest in Inhibrx Biosciences, Inc. (NASDAQ:INBX) Rises By 63.1%
Inhibrx Biosciences, Inc. (NASDAQ:INBX - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 1,712,725...
MarketBeat·2mo ago
<
1
2
...
>

Latest INBX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.